Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by International Biotechnology Trust. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.
With a pandemic sweeping the globe and causing panic in stock markets, investors may be looking for ways to tap into scientific innovation, while also diversifying in the face of a punishing sell-off. Biotechnology ticks both boxes and owning the theme through an investment trust can bring even more benefits.
International Biotechnology- Trust (IBT) invests primarily in US-based drug-makers with a global reach that meet a medical need for consumers. It holds companies from across the space, including established mega caps and smaller, early stage businesses, including some that are unlisted.
IBT is also the only biotech trust which caters to income-seeking investors, offering an attractive dividend of 4% of NAV as well as the potential for rapid capital growth.
Continue reading to find out how IBT harnesses the investment potential in biotechnology...
Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.Continue